Oracle Corporation
ORCL
Delayed Nyse - 07/13 10:01:37 pm
48.63USD
+1%
Prev.48.1500
Open48.0000
High48.8100
Low47.8300
Volume24 857 935
Financials
Sales 2019 40 690 M
EBIT 2019 18 128 M
R. net 2019 11 271 M
Tréso. 2019 8 063 M
Rend. 2019 1,58%
P/E ratio 2019 17,91
P/E ratio 2020 16,35
EV / Sales 2019 4,56x
EV / Sales 2020 4,17x
Capitalization 194 B
Company
Oracle Corp. engages in the provision of products and services in the field of information technology.It operates through the following segments: Cloud and License, Hardware, and Services.The Cloud and License segment markets, sells, and delivers applications, platform, and infrastructure...
Sector :
Enterprise Software
Calendar :
2018-07-16 ORACLE CORPORATION : Ex-dividend day for
Trading Rating :
Investor Rating :
Latest news
07/16ORACLE CORPORATION : Ex-dividend day for
FA
07/12ORACLE : BLOK Technologies Subsidiary Greenstream Networks Joins Oracle Scaleup Ecosystem
AQ
07/12ORACLE : SAM Labs shoots for global STEAM education with help from NetSuite
PR
07/11ORACLE : BLOK Technologies Subsidiary Greenstream Networks Joins Oracle Scaleup Ecosystem
AQ
07/11ORACLE : Media Agencies Conquer Industry Transparency Issues with NetSuite
PR
07/11TODAY'S RESEARCH REPORTS ON TRENDING TICKERS : Zuora and Oracle
AC
07/11ORACLE CORPORATION : Free Post Earnings Research Report: Oracle’s Revenues Advanced 3.3%; Adjusted EPS Surged 11.2%
AC
07/11MARKET SURVEY OF PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET WITH TRENDS, ANALYSIS BY REGIONS, TYPE, APPLICATION AND TOP PLAYERS – GLOBAL FORECAST TO 2023 : This market research report on Pharmacovigilance and Drug Safety Software Market studied By Functionality (Adverse Event Reporting, Fully Integrated Software), Delivery Mode (On-premise, On-demand/Cloud based (SAAS)), End-user (Pharma & Biotech Companies, CROs, BPOs), Organization Size, Companies (ArisGlobal, Ennov Solutions, EXTEDO, Online B
AQ
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralNeutral
Resistance51,053,053,0
Spread/Res.-4,6%-8,2%-8,2%
Spread/Supp.5,9%14%10%
Support45,942,844,1